Gary S. Stetz II - 23 Oct 2026 Form 4 Insider Report for Hepion Pharmaceuticals, Inc. (HEPA)

SEC form
4
Accepted by SEC
27 Oct 2026, 16:30:31 UTC
Prior SEC filing
21 Aug 2026
Source filing
View source filing
Filing notes and source

Key filing fact

Gary S. Stetz II filed Form 4 for Hepion Pharmaceuticals, Inc. (HEPA) on 27 Oct 2026.

Key facts

  • This page summarizes Gary S. Stetz II's Form 4 filing for Hepion Pharmaceuticals, Inc. (HEPA).
  • 1 reported transaction and 1 derivative row are listed below.
  • Accepted by SEC: 27 Oct 2026, 16:30.

Change

  • Previous filing in this sequence was filed on 21 Aug 2026.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0002145064 Primary reporting owner

Stetz Gary S. II

Relationship
Director

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

HEPA transaction Derivative

Stock Options

Award

Transaction value
Shares
+510,000
Change %
+171%
Price
$0.000000*
Shares after
809,000
Date
23 Oct 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
510,000
Exercise price
$0.1400
Footnotes
F1
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

42,500 options vest in equal amounts monthly over 12 months from date of grant.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .